Fifteen-Year Study of the Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus

American Journal of Medicine

Volumn 119, Issue 11, 2006, Pages 943-951

  Crum, Nancy F ^a   Lee, Rachel U ^a   Thornton, Scott A ^b   Stine, O Colin ^c   Wallace, Mark R ^a   Barrozo, Chris ^a   Keefer Norris, Ananda ^c   Judd, Sharon ^a   Russell, Kevin L ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Navy Environmental and Preventive Medicine Unit 6   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Community acquired; Epidemiology; Methicillin resistant Staphylococcus aureus; MRSA

Indexed keywords

ADULT; ARTICLE; BLOOD FLOW; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COMMUNITY; CONTROLLED STUDY; EVALUATION; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; HOSPITAL INFECTION; HUMAN; LUNG INFECTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; UNITED STATES; URINARY TRACT INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; CALIFORNIA; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33750352005     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.01.004     Document Type: Article

References (44)

1. Sheagren J.N. Staphylococcus aureus. The persistent pathogen. N Engl J Med 310 (1984) 1368-1373
2. Jevons M.P. "Celbenin"-resistant staphylococci. BMJ 339 (1998) 520-532
3. Hryniewicz W. Epidemiology of MRSA. Infection 27 (1999) S13-S16
4. Centers for Disease Control. Community-acquired methicillin-resistant Staphylococcus aureus infections-Michigan. MMWR Morb Mortal Wkly Rep 30 (1981) 185-187
5. Salgado C.S., Farr B.M., and Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36 (2002) 131-139
6. Gorak E.J., Yamada S.M., and Brown J.D. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 29 (1999) 797-800
7. Herold B.C., Immergluck L.C., Maranan M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279 8 (1998) 593-598
8. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus, Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 48 (1999) 707-710
9. Zinderman C.E., Conner B., Malakooti M.A., et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 10 (2004) 941-944
10. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus in correctional facilities-Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly. Rep 52 (2003) 992-995
11. Nguyen D.M., Mascola L., and Bancroft E. Recurring infections in a football team. Emerg Infect Dis 11 (2005) 526-532
12. Kazakova S.V., Hageman J.C., Matava M., et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352 (2005) 468-475
13. Charlebois E.D., Perdreau-Remingon F., Kreiswirth B., et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 15 (2004) 47-54
14. Eady E.A., and Cove J.H. Staphylococcal resistance revisited: community-acquired methicillin-resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 16 (2003) 103-124
15. Fey P.D., Said-Salim B., Rupp M.E., et al. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47 (2003) 196-203
16. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 40 (2005) 562-573
17. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 7 2 (2001) 178-182
18. Daum R.S., Ito T., Hiramatsu K., et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 186 (2002) 1344-1347
19. Diep B.A., Sensabaugh G.R., Somboona N.S., et al. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 42 (2004) 2080-2084
20. Francis J.S., Doherty M.C., Lopatin U., et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40 (2005) 100-107
21. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 22 (2003) 2976-2984
22. Almer L.S., Shortridge V.D., Nilius A.M., et al. Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 43 (2002) 225-232
23. Clinical and Laboratory Standards Institute [formerly National Committee for Clinical Laboratory Standards]. Performance standards for antimicrobial disk susceptibility tests (2003), Clinical and Laboratory Standards Institute, Wayne, PA Approved standard M2-A8.
24. Enright M.C., Day N.P., Davies C.E., et al. Multilocus sequence typing for the characterization of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) clones of Staphylococcus aureus. J Clin Microbiol 38 (2000) 1008-1015
25. Ewing B., Hillier L., Wendl M.C., and Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8 (1998) 175-185
26. Ewing B., and Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8 (1998) 186-194
27. Oliveira D.C., Tomasz A., and De Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet 2 (2002) 180-189
28. Lina G., Piemont Y., Godail-Gamot F., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29 (1999) 1128-1132
29. Campbell K.M., Vaughn A.F., Russell K.L., et al. Risk factors for community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections in military trainees: review of an outbreak in San Diego, California, 2002. J Clin Microbiol 42 (2004) 4050-4053
30. Kallen A.J., Driscoll T.J., Thornton S., et al. Increase in community-acquired methicillin-resistant Staphylococcus aureus at a Naval Medical Center. Infect Control Hosp Epidemiol 21 (2000) 223-226
31. Fridkin S.K., Hageman J.C., Morrison M., et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352 (2005) 1436-1444
32. Hollis R.J., Barr J.L., Boebbeling B.N., et al. Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate. Clin Infect Dis 21 (1995) 328-332
33. L'Heritueau F., Lucet J.C., Scanvic A., and Bouvet E. Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission. JAMA 282 (1999) 1038-1039
34. Calfee D.P., Durbin L.J., Germanson T.P., et al. Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA. Infect Control Hosp Epidemiol 24 (2003) 422-426
35. Manian F.A. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis 36 (2003) e26-e28
36. Braun L., Craft D., Williams R., et al. Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 Northeast United States military treatment facilities. Pediatr Infect Dis J 24 (2005) 622-626
37. Lewis II J.S., and Jorgensen J.H. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?. Clin Infect Dis 40 (2005) 280-285
38. Wang C.-C., Lo W.-T., Chu M.-L., and Siu L.K. Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 39 (2004) 481-487
39. Holmes A., Ganner M., McGuane S., et al. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 43 (2005) 2384-2390
40. Faria N.A., Oliveira D.C., Westh H., et al. Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection. J Clin Microbiol 43 (2005) 1836-1842
41. Mishaan A.M.A., Mason Jr. E.O., Martinez-Aguilar G., et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J 24 (2005) 201-206
42. Vandenesch F., Naimi T., Enright M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9 (2003) 978-983
43. Baba T., Takeuchi F., Kuroda M., et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359 (2002) 1819-1827
44. Said-Salim B., Mathema B., Braughton K., et al. Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 43 (2005) 3373-3379